Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 1, 2017

DrugPatentWatch Database Preview

Tiagabine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for tiagabine hydrochloride and what is the scope of tiagabine hydrochloride patent protection?

Tiagabine hydrochloride
is the generic ingredient in two branded drugs marketed by Cephalon and Sun Pharm Inds, and is included in two NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Tiagabine hydrochloride has twenty-four patent family members in twenty-one countries.

There are five drug master file entries for tiagabine hydrochloride. Eight suppliers are listed for this compound.

Summary for Generic Name: tiagabine hydrochloride

Drug Master File Entries: see list5
Suppliers / Packagers: see list8
Bulk Api Vendors: see list35
Clinical Trials: see list994
Patent Applications: see list500
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tiagabine hydrochloride at DailyMed

Pharmacology for Ingredient: tiagabine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
tiagabine hydrochloride
TABLET;ORAL020646-006Nov 29, 2005DISCNNoNo► Subscribe► Subscribe
tiagabine hydrochloride
TABLET;ORAL020646-003Sep 30, 1997RXYesNo5,958,951► Subscribe ► Subscribe
tiagabine hydrochloride
TABLET;ORAL020646-005Apr 16, 1999ABRXYesNo5,958,951► Subscribe ► Subscribe
tiagabine hydrochloride
TABLET;ORAL020646-002Sep 30, 1997RXYesNo5,958,951► Subscribe ► Subscribe
tiagabine hydrochloride
TABLET;ORAL020646-008Nov 29, 2005DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus